Ключевые слова:
COVID-19, buyrak shikastlanishi, patogenez, yallig‘lanish, sitokinlar, endoteliy disfunksiyasi, nefrotoksiklik, ishemiya, apoptoz, nekroz, tubulyar epiteliy, kapillyar vazokonstriksiya, koptokchalar filtratsiyasi tezligi (KFT), immun yondashuv, sitokin bo‘roni.Библиографические ссылки
Abdullaev ShS, Igamberdieva RSh, Sharapov ON. Porazhenie pochek pri COVID-19: kliniko-patogeneticheskie aspekty i vedeniye patsientov s khronicheskoy bolezniyu pochek. Klinicheskaya Nefrologiya. 2021;13(1):63-67. https://doi.org/10.185 65/nephrology.2021.1.63-67
Abdurakhimov A, Kakharov Z. Pathogenetic role of coronavirus infection in the development of acute kidney injury. Am J Med Med Sci. 2024; 14(6):1673-1679. https://doi.org/10.5923/j.ajmms. 20241406.44
Abdurakhimov A. K. et al. Analysis of demographic, clinical and laboratory parameters in COVID-19 patients with acute kidney injury //Clinical nephrology. – 2025. – Т. 17. – №. 1. – С. 33-36.
Abdurakhimov A. K. et al. Pathogenesis of kidney injury in COVID-19 and diabetes mellitus: a review of current concepts //Clinical nephrology. – 2025. – Т. 17. – №. 3. – С. 81-84.
Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020;194:101-115. https://doi.org/ 10.1016/j.thromres.2020.06.029
Adamczak M, Surma S, Więcek A. Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment. Adv Clin Exp Med. 2022;31(3):317-326. https://doi.org/10.17219/ace m/143542
Baklaushev VP, et al. COVID-19. Etiologiya, patogenezi, diagnostika i lechenie. Klinicheskaya praktika. 2020; 11(1):7-20. (In Russ.) https://doi. org/10.17816/clinpract26339
Cheruiyot I, Kipkorir V, Ngure B, et al. Acute kidney injury is associated with worse prognosis in COVID-19 patients: a systematic review and meta-analysis. Acta Biomed. 2020;91(3):19 https:// doi.org/10.23750/abm.v91i3.10222
Drucker DJ. Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocr Rev. 2020;41(3):13. https:// doi.org/10.1210/endrev/bnaa011
Garvin MR, Alvarez C, Miller JI, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife. 2020:16. https://doi.org/10.7554/eLi-fe. 59177
Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia–a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395-403. https:// doi.org/10.1016/j.dsx.2020.04.018
Kiseleva AV, Leskova AV, Skvortsov VV. Patologiya pochek u patsientov s COVID-19. Lechashchiy vrach. 2022;9:19-23. (In Russ.) https:// www.lvrach.ru/2022/09/15438433
Ma M, Wan X, Gao M, et al. Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes. Aging (Albany NY). 2020; 12(7): 5858. https://doi.org/10.18632/aging.10298
Mal'tseva LD, et al. Mekhanizmy ostrogo povrezhdeniya pochek pri Covid-19. Obzor. Nefrologiya i dializ. 2021;23(3):352-365. (In Russ.) https://doi.org/10.28996/2618-9801-2021-3-352-365
Nekaeva ES. Klinicheskoe znachenie pokazateley gemostaza i endotelial'noy disfunktsii u patsientov, perenesshikh novuyu koronavirusnuyu infektsiyu (COVID-19) v pervuyu volnu: dis. kand. med. nauk. Nizhniy Novgorod; 2022:150. (In Russ.)
Shamkhalova MS, Mokrysheva NG, Shestakova MV. COVID-19 and kidneys. Diabetes Mellit. 2020;23(3):235-241. https://doi.org/10.14341/DM 12506
Wang A, et al. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020;162:2. https://doi.org/10.1016/j. diabres.2020.108118
Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. https://doi.org/10.1001 /jama.2020.1585
Zahid U, et al. Acute kidney injury in COVID-19 patients: an inner city hospital experience and policy implications. Am J Nephrol. 2020;5 1 (10):786-796. https://doi.org/10.1159/000511160
Абдурахимов, А. (2023). COVID-19 как триггер в развитии острого почечного повреждения (ОПП) у больных сахарным диабетом. Экспериментальная медицина: сегодня и в будущем, 1(1), 3–4.
Абдурахимов А. Х. и др. Поражение почек у пациентов с COVID-19 //Re-health journal. – 2022. – №. 2 (14). – С. 99-106.
Абдурахимов А. Х. и др. Роль сахарного диабета в развитии поражения почек при COVID-19 //Re-health journal. – 2022. – №. 2 (14). – С. 107-118.
Абдурахимов А. Х. Патогенез развития поражения почек при COVID-19 //re-health journal. – 2022. – №. 4 (16). – с. 1-5.
Гончаров И. М. и др. Респираторные исходы у пациентов, перенесших COVID-19 //Re-health journal. – 2023. – №. 1-2 (17). – С. 1-4.
Кахаров Зафар Абдурахманович, Абдурахимов Абдухалим Холиддин Угли патогенетическая роль коронавирусной инфекции в развитии острого повреждения почек // ejar. 2024. №2-1.